Markets:

Overview

News

Currencies

International

Treasuries

Phathom Pharmaceuticals, Inc. - Common Stock (NQ:PHAT)

15.60 -2.48 (-13.72%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Phathom Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Phathom Pharmaceuticals Provides Update on New Drug Application Review of Vonoprazan for Erosive Esophagitis

January 03, 2023

From Phathom Pharmaceuticals

Via GlobeNewswire

Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors ↗

December 27, 2022

Biopharma stocks were not immune to the broader market downturn seen for much of 2022.

Via Benzinga

NASDAQ:PHAT Shareholder Alert: Investigation over Possible Securities Laws Violations by Phathom Pharmaceuticals, Inc. ↗

November 15, 2022

San Diego, CA -- (SBWIRE) -- 11/15/2022 -- Phathom Pharmaceuticals, Inc is under investigation over potential securities laws violations in connection with certain financial statements.

Via SBWire

Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session ↗

December 13, 2022

Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.

Via Benzinga

Phathom Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Updates

November 08, 2022

From Phathom Pharmaceuticals

Via GlobeNewswire

Phathom Pharmaceuticals to Participate in Upcoming Investor Healthcare Conferences

November 03, 2022

From Phathom Pharmaceuticals

Via GlobeNewswire

Phathom Pharmaceuticals Announces Placement of the Remaining $40 Million in Non-Dilutive Capital under its up to $300 Million Revenue Interest Financing Agreement

November 01, 2022

From Phathom Pharmaceuticals

Via GlobeNewswire

Phathom Pharmaceuticals Completes Patient Enrollment in Phase 3 PHALCON-NERD-301 Daily Dosing Trial of Vonoprazan in Non-Erosive Gastroesophageal Reflux Disease (NERD)

October 24, 2022

From Phathom Pharmaceuticals

Via GlobeNewswire

Phathom Pharmaceuticals Presents New Data Evaluating First-in-Class Potassium-Competitive Acid Blocker (PCAB) Vonoprazan as Novel On-Demand Treatment in NERD at American College of Gastroenterology (ACG) 2022 Annual Scientific Meeting

October 23, 2022

From Phathom Pharmaceuticals

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For October 21, 2022 ↗

October 21, 2022

Upgrades

Via Benzinga

Phathom Pharmaceuticals to Present Latest Data on Vonoprazan at American College of Gastroenterology (ACG) 2022 Annual Scientific Meeting

October 18, 2022

From Phathom Pharmaceuticals

Via GlobeNewswire

NASDAQ:PHAT Investor Notice: Investigation over Possible Wrongdoing at Phathom Pharmaceuticals, Inc. ↗

September 28, 2022

San Diego, CA -- (SBWIRE) -- 09/28/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Phathom Pharmaceuticals, Inc.

Via SBWire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 19, 2022

Via Benzinga

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Investor Notice: Investigation over Possible Violations of Securities Laws ↗

August 17, 2022

San Diego, CA -- (SBWIRE) -- 08/17/2022 -- Phathom Pharmaceuticals, Inc is under investigation over potential securities laws violations connection with certain financial statements.

Via SBWire

Why XPeng Shares Traded Lower By Around 11%; Here Are 77 Biggest Movers From Yesterday ↗

August 24, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 09, 2022

Via Benzinga

Why Windtree Therapeutics Is Trading Higher By Over 60%, Here Are 61 Stocks Moving In Tuesday's Mid-Day Session ↗

August 23, 2022

Gainers

Via Benzinga

PHATHOM ALERT: Bragar Eagel & Squire, P.C. is Investigating Phathom Pharmaceuticals, Inc. on Behalf of Phathom Stockholders and Encourages Investors to Contact the Firm

August 04, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday ↗

August 10, 2022

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.

Via Benzinga

PHATHOM ALERT: Bragar Eagel & Squire, P.C. is Investigating Phathom Pharmaceuticals, Inc. on Behalf of Phathom Stockholders and Encourages Investors to Contact the Firm

August 03, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Phathom Pharmaceuticals, Inc. (PHAT) on Behalf of Investors

August 03, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Phathom Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

August 03, 2022

From The Schall Law Firm

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Phathom Pharmaceuticals, Inc. (PHAT) on Behalf of Investors

August 03, 2022

From Law Offices of Howard G. Smith

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of Phathom Pharmaceuticals, Inc. (PHAT) on Behalf of Investors

August 02, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Phathom Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

August 02, 2022

From The Schall Law Firm

Via Business Wire

Why Shares Of Cannabis Companies Traded Higher; Here Are 101 Biggest Movers From Yesterday ↗

August 03, 2022

Gainers MMTec, Inc. (NASDAQ: MTC) shares gained 390.6% to close at $7.85 on Tuesday amid volatility in nano-cap Chinese stocks.

Via Benzinga

EQUITY ALERT: Rosen Law Firm Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Class Action Investigation – PHAT

August 02, 2022

From The Rosen Law Firm, P.A.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 02, 2022

Via Benzinga

Dow Drops More Than 200 Points; Caterpillar Shares Fall Following Q2 Results ↗

August 02, 2022

U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones tumbling more than 200 points on Tuesday.

Via Benzinga

Why Applied DNA Sciences Is Trading Higher By 166%, Here Are 75 Stocks Moving In Tuesday's Mid-Day Session ↗

August 02, 2022

Gainers AMTD IDEA Group (NYSE: AMTD) shares jumped 284% to $8.00 after jumping 18% on Monday. The company owns 90%+ of AMTD Digital.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.